Join Novalix in October 2024 events

Meet NovAliX in one of our numerous conferences in October 2024 worldwide! Our scientific and business development team will attend the following events, they will be at your disposal to set up a meeting and discuss your drug discovery projects.

CPHI

  • Milan, Italy, from October 8 to 10
  • at Bruker’s booth number 7G89
  • Meet Massimiliano Dal Rio, MSc, Business Development Manager South Europe

This global event will connect the whole pharma industry, from big pharma to SMEs and emerging start-ups. Meet the world of pharma in one place and discuss your therapeutic projects with us!

BioJapan

BioJapan is part of the Asia’s Premier Hybrid Partnering event including also Regenerative Medicine and Health Tech Japan. The event is focused on biotechnology, with exhibitors specializing in drug discovery, medical treatment, research devices, chemical products, environment and energy etc. Many pharmaceutical companies will attend the seminar. Contact our local team to discuss your drug discovery projects!

TipEx Day

  • Strasbourg, France, on October 11
  • Novalix poster presentation entitled: “Development of photocatalyzed reactions under flow conditions
  • Meet Sylvain Guizzetti, PhD, Director Process and Flow Chemistry

The Faculty of Chemistry Chimie of Strasbourg organizes a scientific event dedicated to alternative synthesis techniques such as mechanochemistry, photochemistry, electrosynthesis, and more. It will feature 5 expert talks and experience sharing from 4 young researchers. Sylvain will take part in a roundtable on new skills in organic synthesis and in the poster session. Come to discover the future of chemistry and meet him for in-depth discussions!

12th International Symposium on DNA-Encoded Chemical Libraries

  • Shanghai, China, from October 12 to 13
  • Novalix scientific poster presentation entitled: “Unlocking the reactivity of (hetero)aryl bromides for Sonogashira on-DNA
  • Meet our scientific team: Julien Marin, PhD, SVP Research Services, Michel O., PhD, Director DEL, and Romain Gosmini, PhD, Distinguished Research Fellow Drug Discovery.

DNA-Encoded Chemical Library (DEL) technology is increasingly being applied in the pharmaceutical industry. Major pharmaceutical companies and well-known DEL R&D enterprises participate in the International Symposium on DEL. This 12th edition aims at attracting over 600 from both academies and industries. Novalix is a major player in DEL thanks to its fully integrated DEL platform, transferred from an alliance and license deal with a major pharmaceutical company, and built on the concept of capturing and tracking all experimental information as it is generated from library synthesis through affinity selection.

Festival of Biologics

  • Basel, Switzerland, from October 15 to 17
  • Meet our team: Anne Pecquery, Director Business Development Drug Discovery and Pharmacology, Alessandro Taddei, Director Business Development Drug Discovery, alongside with François Debaene, PhD, Head of Mass Spetrometry, Rémi Longuespée, PhD, Project Manager in Mass Spectrometry, and Johann Stojko, PhD, Senior Project Manager in Mass Spectrometry.

The Festival of Biologics is one of the Europe’s largest event dedicated to biologics. It will feature over 350 speakers, 150 exhibitors and more than 3,000 attendees are expected. Bringing together pharma and biotech, academics, research institutes, regulators, and patients groups, it covers the biologics value chain from discovery to market.

LCSB Industry Partnering Day

The LCSB Industry Partnering Day is an invite-only event for industry partners representing sectors such as pharmaceuticals, biotechnology, digital healthtech and CROs.

Drug Discovery Biology & Bioinformatics

  • London, UK, on October 22
  • Meet Frank Moffatt, Senior Director of Business Development

Drug Discovery Biology & Bioinformatics 2024 is part of Proventa International’s Strategy Meetings Europe 2024. Committed to delivering long-term value across their life science network, the event is a platform for creating life-saving therapies. It is dedicated to “the physiological context and quality of drug target characterization, validation, and safety profiling throughout the preclinical space”.

Medicinal Chemistry

  • London, UK, on October 23
  • Meet Frank Moffatt, Senior Director of Business Development

Medicinal Chemistry is part of Proventa International’s Strategy Meetings Europe 2024, focusing on “pharma and biotech R&D through advanced technologies and innovative techniques”. If you are looking for a partnership to develop drug discovery projects or to discuss about medchem projects, just contact us!

Novalix is changing the future of drug discovery with a fresh new look.

The new website is currently
under construction.

NovAliX